NAT10-mediated lipid metabolic reprogramming drives EGFR-TKI resistance in non-small cell lung cancer via ac4C-dependent mRNA stabilization
NAT10介导的脂质代谢重编程通过ac4C依赖的mRNA稳定作用驱动非小细胞肺癌的EGFR-TKI耐药性
期刊:Experimental Hematology & Oncology
影响因子:13.5
doi:10.1186/s40164-025-00721-9
Fang, Shuai; Zhu, Yuchao; Chen, Wei; Mao, Wei; Fang, Yuan; Chen, Ziyuan; Hong, Zhiqi; Zhao, Xiaodong; Su, Wenmin; Pan, Yuning; Yao, Guangyu; Wang, Jianhua; Zhou, Chengwei
肺癌
NAT10
肿瘤
肿瘤免疫
EGF
代谢
代谢重编程
EGFR
细胞生物学
